FundedIQ
Biotechnology

Endra: Funding, Investors & Team (Sep 2026)

Endra, Inc. provides photoacoustic products and medical imaging technologies in the United States. It offers Nexus 128, a preclinical photoacoustic computed tomography scanner for small animal imaging, as well as is used for non-invasive quantification of tumor vasculature and other physiological parameters for preclinical research. The company’s products provide rapid functional images of structures, such as tumors, blood vessels, lymph nodes, and other tissues. Endra, Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

endrainc.com LinkedIn Ann Arbor, United States 11-50 employees
Total raised
$13.6M
Rounds
2
Latest
Undisclosed round
Oct 2025

Endra has raised $13.6M across 2 funding rounds on record, the most recent an undisclosed round of $4.9M announced in Oct 2025.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Endra Company Profile and Key Stats

Total funding raised
$13.6M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Undisclosed round
$4.9M in Oct 2025
Employees
11-50
reported band
Headquarters
Ann Arbor, United States

Latest funding round on record: Oct 2025.

Endra Funding Rounds

Date
Round
Amount
Undisclosed round
$4.9M
Post-IPO Equity
$8.7M

Endra raised $8.7M in a Post-IPO Equity announced in Apr 2022.

3.5 years later, an undisclosed round of $4.9M was announced in Oct 2025.

Endra Founders and Leadership Team

Name
Role
Contact
Jonathan Behr
Founder

No contact details are on record for this team yet.

Endra Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M

Endra's latest round of $4.9M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Endra in Biotechnology and Ann Arbor

Companies Similar to Endra

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Endra Funding FAQs

What does Endra do?

Endra, Inc. provides photoacoustic products and medical imaging technologies in the United States. It offers Nexus 128, a preclinical photoacoustic computed tomography scanner for small animal imaging, as well as is used for non-invasive quantification of tumor vasculature and other physiological parameters for preclinical research. The company’s products provide rapid functional images of structures, such as tumors, blood vessels, lymph nodes, and other tissues. Endra, Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

How much funding has Endra raised?

Endra has raised $13.6M across 2 rounds on record. The most recent is an undisclosed round of $4.9M announced in Oct 2025.

When did Endra last raise funding?

Endra's most recent funding round on record is an undisclosed round of $4.9M, announced in Oct 2025.

Who founded Endra?

FundedIQ lists Jonathan Behr (Founder) at Endra.

Where is Endra headquartered?

Endra is based in Ann Arbor, Michigan, United States.

How many employees does Endra have?

Endra is in the 11-50 employee band.

How does Endra's funding compare to other Biotechnology startups?

Endra's latest round of $4.9M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Endra Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Endra is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.